Jacobson Pharma Corp. Ltd. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Mar'18

Mar'17

Net Sales

1,785.58

1,595.54

1,445.91

1,571.46

1,478.12

1,548.68

1,255.96

Other Operating Income

0.00

Total Operating income

1,785.58

1,595.54

1,445.91

1,571.46

1,478.12

1,548.68

1,255.96

Raw Material Cost

1,038.41

975.02

911.77

901.70

823.42

931.02

699.07

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

471.31

424.02

403.35

454.46

418.18

417.09

377.93

Power Cost

0.00

Manufacturing Expenses

67.44

25.69

30.14

55.36

66.20

46.01

14.00

Selling and Distribution Expenses

426.90

390.99

346.86

370.59

318.64

336.93

327.04

Other Expenses

-53.76

-44.31

-43.17

-50.61

-48.18

-46.08

-38.56

Total Expenditure (Excl Depreciation)

1,466.48

1,372.65

1,260.41

1,276.02

1,144.60

1,270.25

1,032.45

Operating Profit (PBDIT) excl Other Income

319.1

222.89999999999998

185.5

295.4

333.5

278.4

223.5

Other Income

57.27

28.90

19.86

20.67

13.69

6.14

11.74

Operating Profit (PBDIT)

560.83

444.39

397.07

482.37

462.94

397.01

317.22

Interest

67.44

25.69

30.14

55.36

66.20

46.01

14.00

Exceptional Items

34.39

9.10

50.87

2.11

23.37

12.65

0.00

Gross Profit (PBDT)

747.17

620.52

534.15

669.76

654.70

617.66

556.89

Depreciation

184.46

192.60

191.70

166.27

115.73

112.43

81.98

Profit Before Tax

343.31

235.20

226.10

262.86

304.39

251.22

221.25

Tax

56.55

43.73

34.26

46.02

55.53

46.32

39.99

Provisions and contingencies

0.00

Profit After Tax

251.04

177.67

173.71

214.49

246.79

202.27

179.33

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

251.04

177.67

173.71

214.49

246.79

202.27

179.33

Share in Profit of Associates

0.00

Minority Interest

32.16

10.04

12.60

2.97

6.78

2.63

1.93

Other related items

0.00

Consolidated Net Profit

283.21

187.71

186.31

217.46

253.58

204.90

181.26

Equity Capital

0.00

Face Value

0.01

Reserves

2,736.69

2,491.32

2,389.85

2,537.74

2,647.17

1,975.76

1,749.40

Earnings per share (EPS)

0.13

0.09

0.11

0.13

0.11

Diluted Earnings per share

0.13

0.09

0.11

0.13

0.11

Operating Profit Margin (Excl OI)

17.87%

13.97%

12.83%

18.8%

22.56%

17.98%

17.8%

Gross Profit Margin

29.56%

26.81%

28.89%

27.31%

28.42%

23.48%

24.14%

PAT Margin

14.06%

11.14%

12.01%

13.65%

16.7%

13.06%

14.28%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2023 is 11.91% vs 10.35% in Mar 2022

Consolidate Net Profit

YoY Growth in year ended Mar 2023 is 50.88% vs 0.75% in Mar 2022

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2023 is 21.20% vs 10.15% in Mar 2022

Interest

YoY Growth in year ended Mar 2023 is 162.26% vs -14.62% in Mar 2022

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2023 has improved from Mar 2022

Compare Annual Results Of Jacobson Pharma Corp. Ltd. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(HKD)

Change(%)

Net Sales

1,785.58

520.32

1,265.26

243.17%

Other Operating Income

0.00

Total Operating income

1,785.58

520.32

1,265.26

243.17%

Raw Material Cost

1,038.41

332.40

706.01

212.40%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

471.31

89.02

382.29

429.44%

Power Cost

0.00

Manufacturing Expenses

67.44

8.21

59.23

721.44%

Selling and Distribution Expenses

426.90

120.15

306.75

255.31%

Other Expenses

-53.76

-9.72

-44.04

-453.09%

Total Expenditure (Excl Depreciation)

1,466.48

452.55

1,013.93

224.05%

Operating Profit (PBDIT) excl Other Income

319.10

67.77

251.33

370.86%

Other Income

57.27

14.18

43.09

303.88%

Operating Profit (PBDIT)

560.83

125.58

435.25

346.59%

Interest

67.44

8.21

59.23

721.44%

Exceptional Items

34.39

5.09

29.30

575.64%

Gross Profit (PBDT)

747.17

187.92

559.25

297.60%

Depreciation

184.46

43.63

140.83

322.78%

Profit Before Tax

343.31

78.83

264.48

335.51%

Tax

56.55

13.57

42.98

316.73%

Provisions and contingencies

0.00

Profit After Tax

251.04

57.09

193.95

339.73%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

251.04

57.09

193.95

339.73%

Share in Profit of Associates

0.00

Minority Interest

32.16

6.24

25.92

415.38%

Other related items

0.00

Consolidated Net Profit

283.21

63.33

219.88

347.20%

Equity Capital

0.00

Face Value

0.01

0.00

Reserves

2,736.69

985.51

1,751.18

177.69%

Earnings per share (EPS)

0.13

0.06

0.07

116.67%

Diluted Earnings per share

0.13

0.06

0.07

116.67%

Operating Profit Margin (Excl OI)

17.87%

13.02%

0.00

4.85%

Gross Profit Margin

29.56%

23.54%

0.00

6.02%

PAT Margin

14.06%

10.97%

0.00

3.09%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 178.56 Million

in Mar 2023

Figures in Million

YoY Growth in year ended Mar 2023 is 11.91% vs 10.35% in Mar 2022

Annual - Consolidate Net Profit

Consolidate Net Profit 28.32 Million

in Mar 2023

Figures in Million

YoY Growth in year ended Mar 2023 is 50.88% vs 0.75% in Mar 2022

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 50.36 Million

in Mar 2023

Figures in Million

YoY Growth in year ended Mar 2023 is 21.20% vs 10.15% in Mar 2022

Annual - Interest

Interest 6.74 Million

in Mar 2023

Figures in Million

YoY Growth in year ended Mar 2023 is 162.26% vs -14.62% in Mar 2022

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 17.87%

in Mar 2023

Figures in %

YoY Growth in year ended Mar 2023 has improved from Mar 2022